The European Medicines Agency could this week recommend that Gilead Sciences’ antiviral drug remdesivir be approved for treating COVID-19 across the EU.
Gilead is seeking conditional approval for remdesivir in the EU and the marketing authorization application (MAA) for the investigational drug...








